Dewei Shang

机构：Guangzhou Psychiatric Hospital, Guangzhou Medical University

发表论文 97 篇 · 总被引 1682 次 · h-index 19

代表论文

• Inulin alleviates chronic ketamine-induced impairments in memory and prepulse inhibition by regulating the gut microbiota, inflammation, and kynurenine pathway (2025 · International Journal of Biological Macromolecules · 被引 17)
• Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial (2024 · Journal of Affective Disorders · 被引 14)
• Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation in adolescents with first-episode major depressive disorder: A randomized, double-blind, sham-controlled pilot trial (2024 · Journal of Affective Disorders · 被引 12)
• Exploring the correlation between cardiovascular adverse events and antidepressant use: A retrospective pharmacovigilance analysis based on the FDA Adverse Event Reporting System database (2024 · Journal of Affective Disorders · 被引 11)
• The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis (2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 被引 10)
• The pharmacological actions of Danzhi-xiaoyao-San on depression involve lysophosphatidic acid and microbiota-gut-brain axis: novel insights from a systems pharmacology analysis of a double-blind, randomized, placebo-controlled clinical trial (2023 · Journal of Biomolecular Structure and Dynamics · 被引 9)